6397 RESULTS
Sort By:
Aβ oligomers rapidly seed tau pathology in macaques, potentially providing a model for drug testing that better reflects human pathology.Aβ oligomers rapidly seed tau pathology in macaques, potentially providing a model for drug testing that better reflects human pathology.
By beaming red light at a blood sample and measuring the scattered photons, scientists claim to identify people with Alzheimer’s disease.
The severity of ALS correlates with how badly mutations destabilize superoxide dismutase 1, and promote its aggregation, according to a new study.
MRI in mice could help explain disconnections in neural circuitry that precede amyloid plaques.
A broad genetic analysis suggests that mutations in a microtubule subunit enhance the risk for ALS.
Compounds derived from cocoa beans boost blood volume to part of the brain, and may counteract age-related decline in memory.
A small Aβ fragment produced in healthy brains binds acetylcholine receptors and enhances synaptic plasticity and learning, while blocking the toxic effects of Aβ42.
A drug that inhibits the sodium/potassium pump rescues a mouse model of the disease.
Compound clears Phase 1 hurdle.
Scientific advances fire up researchers at FTD meeting in a dreary Vancouver.
Vancouver Frontotemporal Dementia Conference Shows Awakening Field First Data from GENFI1: Brain’s Insula Region Shrinks A Decade Before FTD German Network of 700 FTLD Patients Presents Baseline Data Meet the Artful Leftie: NIH Jump-Starts U.S.-Canadian F
Primates tolerate treatment with bispecific antibodies that smuggle anti-BACE1 across the blood-brain barrier.
Standardized scale to harmonize results from different imaging strategies.
Researchers claim basic conclusions still sound.
Term covers tauopathy in the absence of Aβ, regardless of cognitive state.
